170 related articles for article (PubMed ID: 38654944)
21. Clinical and Epidemiologic Features of Visceral Leishmaniasis in Children: A 6-year Study from an Iranian Referral Hospital.
Abdolsalehi M; Pourakbari B; Mahmoudi S; Moradzadeh M; Keshavarz H; Mamishi S
Infect Disord Drug Targets; 2020; 20(4):461-466. PubMed ID: 31203810
[TBL] [Abstract][Full Text] [Related]
22. Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis.
Silva Ferreira de Carvalho IP; Peixoto HM; Sierra Romero GA; Fernandes de Oliveira MR
Value Health Reg Issues; 2020 Dec; 23():77-84. PubMed ID: 32961526
[TBL] [Abstract][Full Text] [Related]
23. [Evaluation of clinical and laboratory findings of adult visceral leishmaniasis cases].
Ural S; Kaptan F; Sezak N; El S; Örmen B; Türker N; Demirdal T; Vardar İ; Özkan Çayıröz P; Çakalağaoğlu F
Mikrobiyol Bul; 2015 Oct; 49(4):586-93. PubMed ID: 26649416
[TBL] [Abstract][Full Text] [Related]
24. [Visceral childhood leishmaniasis: diagnosis and treatment].
Prieto Tato LM; La Orden Izquierdo E; Guillén Martín S; Salcedo Lobato E; García Esteban C; García-Bermejo I; Ramos Amador JT
An Pediatr (Barc); 2010 May; 72(5):347-51. PubMed ID: 20378427
[TBL] [Abstract][Full Text] [Related]
25. Varied spectrum of clinical presentation and mortality in a prospective registry of visceral leishmaniasis in a low endemicity area of Northern Italy.
Cenderello G; Pasa A; Dusi A; Dentone C; Toscanini F; Bobbio N; Bondi E; Del Bono V; Izzo M; Riccio G; Anselmo M; Giacchino R; Marazzi MG; Pagano G; Cassola G; Viscoli C; Ferrea G; De Maria A
BMC Infect Dis; 2013 May; 13():248. PubMed ID: 23718708
[TBL] [Abstract][Full Text] [Related]
26. [Childhood visceral leishmaniasis in Provence].
Minodier P; Garnier JM
Arch Pediatr; 2000 Jun; 7 Suppl 3():572s-577s. PubMed ID: 10941482
[TBL] [Abstract][Full Text] [Related]
27. Visceral leishmaniasis in Kosovo: A case of misdiagnosis and diagnostic challenges.
Tolaj I; Mehmeti M; Gashi H; Berisha F; Gashi V; Fejza H; Shala N
IDCases; 2023; 32():e01768. PubMed ID: 37131489
[TBL] [Abstract][Full Text] [Related]
28. A severe case of visceral leishmaniasis and liposomal amphotericin B treatment failure in an immunosuppressed patient 15 years after exposure.
Eichenberger A; Buechi AE; Neumayr A; Hatz C; Rauch A; Huguenot M; Diamantis-Karamitopoulou E; Staehelin C
BMC Infect Dis; 2017 Jan; 17(1):81. PubMed ID: 28095796
[TBL] [Abstract][Full Text] [Related]
29. Clinical and Microbiological Characteristics of Visceral Leishmaniasis Outbreak in a Northern Italian Nonendemic Area: A Retrospective Observational Study.
Franceschini E; Puzzolante C; Menozzi M; Rossi L; Bedini A; Orlando G; Gennari W; Meacci M; Rugna G; Carra E; Codeluppi M; Mussini C
Biomed Res Int; 2016; 2016():6481028. PubMed ID: 27999807
[No Abstract] [Full Text] [Related]
30. Visceral leishmaniasis (Kala-azar) in Qom Province, Iran: Report of two cases.
Zanjirani Farahani L; Saghafipour A; Mohebali M; Akhoundi B; Raufi H
F1000Res; 2018; 7():1371. PubMed ID: 31281631
[TBL] [Abstract][Full Text] [Related]
31. Risk factors for visceral leishmaniasis relapse in immunocompetent patients following treatment with 20 mg/kg liposomal amphotericin B (Ambisome) in Bihar, India.
Burza S; Sinha PK; Mahajan R; Lima MA; Mitra G; Verma N; Balasegaram M; Das P
PLoS Negl Trop Dis; 2014; 8(1):e2536. PubMed ID: 24392166
[TBL] [Abstract][Full Text] [Related]
32. Efficacy and safety of single-dose liposomal amphotericin B for visceral leishmaniasis in a rural public hospital in Bangladesh: a feasibility study.
Mondal D; Alvar J; Hasnain MG; Hossain MS; Ghosh D; Huda MM; Nabi SG; Sundar S; Matlashewski G; Arana B
Lancet Glob Health; 2014 Jan; 2(1):e51-7. PubMed ID: 25104636
[TBL] [Abstract][Full Text] [Related]
33. Visceral leishmaniasis in Iran: Review of the Epidemiological and Clinical Features.
Mohebali M
Iran J Parasitol; 2013 Jul; 8(3):348-58. PubMed ID: 24454426
[TBL] [Abstract][Full Text] [Related]
34. Single-dose liposomal amphotericin B for visceral leishmaniasis in India.
Sundar S; Chakravarty J; Agarwal D; Rai M; Murray HW
N Engl J Med; 2010 Feb; 362(6):504-12. PubMed ID: 20147716
[TBL] [Abstract][Full Text] [Related]
35. [Infantile visceral leishmaniasis in the Campania region, Italy: experience from a Paediatric Referral Centre].
di Martino L; Gramiccia M; Occorsio P; Di Muccio T; Scalone A; Gradoni L
Parassitologia; 2004 Jun; 46(1-2):221-3. PubMed ID: 15305721
[TBL] [Abstract][Full Text] [Related]
36. Visceral leishmaniasis and HIV co-infection in Bihar, India: long-term effectiveness and treatment outcomes with liposomal amphotericin B (AmBisome).
Burza S; Mahajan R; Sinha PK; van Griensven J; Pandey K; Lima MA; Sanz MG; Sunyoto T; Kumar S; Mitra G; Kumar R; Verma N; Das P
PLoS Negl Trop Dis; 2014 Aug; 8(8):e3053. PubMed ID: 25101665
[TBL] [Abstract][Full Text] [Related]
37. Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?
Horrillo L; Castro A; Matía B; Molina L; García-Martínez J; Jaqueti J; García-Arata I; Carrillo E; Moreno J; Ruiz-Giardin JM; San Martín J
Parasit Vectors; 2019 Jul; 12(1):359. PubMed ID: 31340851
[TBL] [Abstract][Full Text] [Related]
38. Liposomal amphotericin B for the treatment of visceral leishmaniasis.
Bern C; Adler-Moore J; Berenguer J; Boelaert M; den Boer M; Davidson RN; Figueras C; Gradoni L; Kafetzis DA; Ritmeijer K; Rosenthal E; Royce C; Russo R; Sundar S; Alvar J
Clin Infect Dis; 2006 Oct; 43(7):917-24. PubMed ID: 16941377
[TBL] [Abstract][Full Text] [Related]
39. Liposomal amphotericin B for complicated visceral leishmaniasis (kala-azar) in eastern Sudan: how effective is treatment for this neglected disease?
Salih NA; van Griensven J; Chappuis F; Antierens A; Mumina A; Hammam O; Boulle P; Alirol E; Alnour M; Elhag MS; Manzi M; Kizito W; Zachariah R
Trop Med Int Health; 2014 Feb; 19(2):146-52. PubMed ID: 24433217
[TBL] [Abstract][Full Text] [Related]
40. Clinical and laboratory profiles of visceral leishmaniasis among adult patients admitted to Felege Hiwot Hospital, Bahir Dar, Ethiopia.
Tarekegn B; Tamene A
SAGE Open Med; 2021; 9():20503121211036787. PubMed ID: 34377476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
